HCAT vs XLI
Health Catalyst Inc (HCAT) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
XLI (XLI) common stock.
Latest reported HCAT revenue for 2026-06-30 was $141.2M. Net income was -$151.6M. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. HCAT currently screens at market cap $130.8M.
XLI does not have a complete income-statement cache yet.
HCAT currently screens at market cap $130.8M. XLI currently screens at market cap $0.
Not investment advice. Open the HCAT and XLI stock pages for the full models.
Not investment advice.